ELIZABETH HARDY: Open Payments
NPI 1598422636 · GREENWOOD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 60 payments from 13 companies in 2025. Trend: 2023 $418 · 2024 $1,308 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $235 |
| PFIZER INC. | 16 | $195 |
| Amgen Inc. | 11 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $82 |
| Lundbeck LLC | 2 | $46 |
| Lilly USA, LLC | 2 | $37 |
| Antares Pharma, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: NURTEC ODT, FARXIGA, OTEZLA, QULIPTA, VRAYLAR, Kerendia, REXULTI, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
